Last $77.17 USD
Change Today +0.55 / 0.72%
Volume 684.0K
ABC On Other Exchanges
Symbol
Exchange
Berlin
As of 11:23 AM 10/22/14 All times are local (Market data is delayed by at least 15 minutes).

amerisourcebergen corp (ABC) Snapshot

Open
$76.90
Previous Close
$76.62
Day High
$77.19
Day Low
$76.59
52 Week High
07/24/14 - $79.13
52 Week Low
04/25/14 - $62.55
Market Cap
17.3B
Average Volume 10 Days
2.0M
EPS TTM
$1.18
Shares Outstanding
224.4M
EX-Date
08/14/14
P/E TM
65.4x
Dividend
$0.94
Dividend Yield
1.23%
Current Stock Chart for AMERISOURCEBERGEN CORP (ABC)

amerisourcebergen corp (ABC) Details

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; scalable automated pharmacy dispensing equipment; medication and supply dispensing cabinets; and packaging solutions to institutional and retail healthcare providers. In addition, this segment provides pharmaceutical distribution and other services primarily to physician practices in various disease states, such as oncology, as well as to other healthcare providers, including dialysis clinics; distributes plasma and other blood products, injectible pharmaceuticals, and vaccines; and third party logistics and outcomes research, and other services for biotechnology and other pharmaceutical manufacturers. The company’s Other segment provides commercialization support services, including reimbursement support programs, outcomes research, contract field staffing, patient assistance and copay assistance programs, adherence programs, risk mitigation services, and other market access programs to pharmaceutical and biotechnology manufacturers; and specialty transportation and logistics services for the biopharmaceutical industry. AmerisourceBergen Corporation markets its products and services through independent sales forces and marketing organizations. The company was founded in 1985 and is based in Chesterbrook, Pennsylvania.

12,000 Employees
Last Reported Date: 11/26/13
Founded in 1985

amerisourcebergen corp (ABC) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.2M
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $500.0K
Senior Vice President and President of Ameris...
Total Annual Compensation: $600.0K
Senior Vice President and President of Ameris...
Total Annual Compensation: $400.0K
Executive Vice President and General Counsel
Total Annual Compensation: $462.0K
Compensation as of Fiscal Year 2013.

amerisourcebergen corp (ABC) Key Developments

AmerisourceBergen Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 08:35 AM

AmerisourceBergen Corporation Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 08:35 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Steven H. Collis, Chief Executive Officer, President, Director and Chairman of Executive Committee.

AmerisourceBergen Corporation Declares Quarterly Dividend Payable September 2, 2014

The Board of Directors of AmerisourceBergen Corporation declared a quarterly dividend of $0.235 per common share, payable September 2, 2014, to stockholders of record at the close of business on August 18, 2014.

Amerisourcebergen Corporation Announces Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended June 30, 2014; Revised Earnings Guidance for the Year of 2014

AmerisourceBergen Corporation announced unaudited consolidated financial results for the third quarter and nine months ended June 30, 2014. For the quarter, the company reported net loss of $12.780 million or $0.06 per diluted share against net income of $168.439 million or $0.73 per diluted share a year ago. Revenue was $30,348,154,000 against $21,906,648,000 a year ago. Loss from continuing operations was $12.780 million or $0.06 per diluted share against income from continuing operations of $64.110 million or $0.27 per diluted share a year ago. Operating income was $110.877 million against $134,646 million a year ago. Income before income taxes was $58.332 million against $115.931 million a year ago. Adjusted non-GAAP operating income was $393.473 million against $312.328 million a year ago. Adjusted non-GAAP income before income tax was $374.808 million against $293.613 million a year ago. Adjusted non-GAAP income from continuing operations was $232.381 million or $1.01 per diluted share against $183.802 million or $0.78 per diluted share a year ago. For the nine months, the company reported net income of $208.682 million or $0.89 per diluted share against $382.684 million or $1.63 per diluted share a year ago. Revenue was $87,980,419,000 against $63,490,127,000 a year ago. Income from continuing operations was $216.228 million or $0.92 per diluted share against $442.874 million or $1.88 per diluted share a year ago. Net cash provided by operating activities was $632.495 million against $819.064 million a year ago. Operating income was $571.621 million against $784.209 million a year ago. Income before income taxes was $485.150 million against $727.733 million a year ago. Adjusted non-GAAP operating income was $1,132.767 million against $964.742 million a year ago. Adjusted non-GAAP income before income tax was $1,080.176 million against $908.266 million a year ago. Adjusted non-GAAP income from continuing operations was $668.298 million or $2.86 per diluted share against $564.621 million or $2.40 per diluted share a year ago. The company now expects adjusted diluted earnings per share from continuing operations in fiscal year 2014 to be in the range of $3.89 to $3.94, an increase of 21 to 23% over fiscal 2013. The company expects revenue growth in the 35% range, and operating income growth in the high-teens percentage range. Adjusted operating margin is expected to decline in the high-teens basis points range due to the onboarding of significant new lower margin business and growth in brand pharmaceutical business with large customers. The company now expects free cash flow to be in the high end of the range of $500 to $700 million, with capital expenditures in the $275 million range, and to spend approximately $500 million in share repurchases, subject to market conditions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABC:US $77.17 USD +0.55

ABC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $76.74 USD +0.91
Henry Schein Inc $116.37 USD +0.06
McKesson Corp $197.86 USD +0.93
Omnicare Inc $64.76 USD +0.53
Tractor Supply Co $61.92 USD +0.46
View Industry Companies
 

Industry Analysis

ABC

Industry Average

Valuation ABC Industry Range
Price/Earnings 66.6x
Price/Sales 0.2x
Price/Book 8.5x
Price/Cash Flow 38.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMERISOURCEBERGEN CORP, please visit www.amerisourcebergen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.